Figure 2: Adjusted Cohen Mansfield Agitation Inventory score by treatment
group and time (higher scores indicate greater agitation)
CMAI

—♦— DCM
—•— PCC
—UC UC
Table 2: Annual Pharmaceutical Costs Per Resident
Mean, standard |
DCM |
PCC |
UC |
Total | |
Period |
Pre- Intervention |
598.44 (906.30) |
647.35 (790.39) |
473.25 (905.64) |
579.51 (868.34) |
Post- Intervention |
617.72 (955.06) |
597.89 (852.35) |
363.00 (852.75) |
541.45 (897.13) | |
Follow-up |
542.21 (883.32) |
560.49 (823.68) |
398.19 (871.16) |
508.10 (860.10) | |
Total |
587.31 (913.29) |
605.37 (818.91) |
414.96 (875.68) |
545.55 (874.88) |
Pair-wise t-tests were run on this information, investigating whether the
pharmaceutical costs per person at a time point were statistically significantly
different from the observed mean. In the nine pair-wise comparisons, none were
statistically significant at the 5% level. Therefore, as the mean difference between
More intriguing information
1. An Efficient Secure Multimodal Biometric Fusion Using Palmprint and Face Image2. GENE EXPRESSION AND ITS DISCONTENTS Developmental disorders as dysfunctions of epigenetic cognition
3. Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6
4. EXECUTIVE SUMMARIES
5. Großhandel: Steigende Umsätze und schwungvolle Investitionsdynamik
6. The name is absent
7. WP 36 - Women's Preferences or Delineated Policies? The development or part-time work in the Netherlands, Germany and the United Kingdom
8. The Cost of Food Safety Technologies in the Meat and Poultry Industries.
9. If our brains were simple, we would be too simple to understand them.
10. The name is absent